Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors.
We report 3 cases of herpes simplex virus encephalitis in patients receiving tumor necrosis factor-alpha (TNF-alpha) inhibitors for rheumatologic disorders. Although TNF-alpha inhibitors have been reported to increase the risk of other infectious diseases, to our knowledge, an association between anti-TNF-alpha drugs and herpes simplex virus encephalitis has not been previously described.
Bradford
Russell D
RD
Division of Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35233, USA. rbradford@peds.uab.edu
Pettit
April C
AC
Wright
Patty W
PW
Mulligan
Mark J
MJ
Moreland
Larry W
LW
McLain
David A
DA
Gnann
John W
JW
Bloch
Karen C
KC
D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D020803:Encephalitis, Herpes Simplex / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D018259:Herpesvirus 1, Human / Q000302:isolation & purification; D018258:Herpesvirus 2, Human / Q000302:isolation & purification; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D012216:Rheumatic Diseases / Q000150:complications* / Q000188:drug therapy; D012307:Risk Factors; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000998:Antiviral Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab
Arthritis Rheum. 2007 Sep;56(9):2896-904
17763441
J Infect Dis. 1982 Jun;145(6):829-36
6282983
Clin Infect Dis. 2005 Aug 1;41 Suppl 3:S208-12
15983902
J Med Case Rep. 2008 Aug 26;2:282
18727822
JAMA. 2006 May 17;295(19):2275-85
16705109
JAMA. 2009 Feb 18;301(7):737-44
19224750
Scand J Infect Dis. 2008;40(1):59-62
17852910
Clin Infect Dis. 2005 Aug 1;41 Suppl 3:S189-93
15983898
J Neurol Sci. 1998 May 7;157(2):148-53
9619637
Clin Infect Dis. 2008 Aug 1;47(3):303-27
18582201
J Infect Dis. 2007 Sep 15;196(6):853-60
17703415
Science. 2007 Sep 14;317(5844):1522-7
17872438
J Infect Dis. 1995 Apr;171(4):857-63
7706811
Clin Infect Dis. 2007 Oct 1;45(7):875-80
17806053
Pediatrics. 2001 Aug;108(2):230-8
11483782
Clin Infect Dis. 2002 Apr 15;34(8):1154-7
11915008